ConCallIQ
Go Pro
COROMANDEL Diversified 30 Jan 2025

Coromandel International Limited — Q3 FY25

Coromandel reported a stellar Q3 FY25 with consolidated revenue of INR 7,049 crore (+28% YoY) and EBITDA of INR 722 crore (+102% YoY), driven by record NPK volumes (11.4 lakh to...

bullish high
Compare with...
Revenue ₹7,049 Cr +28%
EBITDA ₹722 Cr +101.68%
PAT ₹508 Cr +122.81%
EBITDA Margin 10.24% +370bps
Duration
Read Time 1 min read

Financial stats pending filing verification

Risk Intelligence

Material risks this quarter

Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.

Risks

R

Subsidy under-recovery in Q4

Management noted that DAP margins are not adequate due to raw material cost increases; representation to government ongoing, but correction may not happen before April.

medium · management_commentary
R

Raw material price volatility (sulfur/sulfuric acid)

Sudden spike in sulfur and sulfuric acid prices due to demand from China and Indonesia could impact input costs.

medium · management_commentary
R

Delays in securing export orders for bioproducts

Export volumes in bioproducts were impacted due to delays in order finalization, though expected to recover in Q4.

low · management_commentary
R

Competition and pricing pressure in crop protection exports

Analyst raised concern about pricing-led competition in export markets; management acknowledged but highlighted diversification and formulation foray as mitigants.

medium · analyst_question